Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

De novo developed protein binders mimicking Interferon lambda signaling

L. Kolářová, J. Zahradník, M. Huličiak, P. Mikulecký, Y. Peleg, M. Shemesh, G. Schreiber, B. Schneider

. 2022 ; 289 (9) : 2672-2684. [pub] 20211207

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc22018559

We hereby describe the process of design and selection of nonantibody protein binders mimicking cytokine signaling. We chose to mimic signaling of IFN-λ1, type 3 interferon (also known as IL-29) for its novelty and the importance of its biological functions. All four known interferons λ signal through binding to the extracellular domains of IL-28 receptor 1 (IL-28R1) and IL-10 receptor 2 (IL-10R2). Our binders were therefore trained to bind both receptors simultaneously. The bifunctional binder molecules were developed by yeast display, a method of directed evolution. The signaling capacity of the bivalent binders was tested by measuring phosphorylation of the JAK/STAT signaling pathway and production of mRNA of six selected genes naturally induced by IFN- λ1 in human cell lines. The newly developed bivalent binders offer opportunities to study cytokine-related biological functions and modulation of the cell behavior by receptor activation on the cell surfaces alternative to the use of natural IFN-λ.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22018559
003      
CZ-PrNML
005      
20220804134847.0
007      
ta
008      
220720s2022 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1111/febs.16300 $2 doi
035    __
$a (PubMed)34826176
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Kolářová, Lucie $u Institute of Biotechnology of the Czech Academy of Sciences, BIOCEV, Vestec, Czech Republic
245    10
$a De novo developed protein binders mimicking Interferon lambda signaling / $c L. Kolářová, J. Zahradník, M. Huličiak, P. Mikulecký, Y. Peleg, M. Shemesh, G. Schreiber, B. Schneider
520    9_
$a We hereby describe the process of design and selection of nonantibody protein binders mimicking cytokine signaling. We chose to mimic signaling of IFN-λ1, type 3 interferon (also known as IL-29) for its novelty and the importance of its biological functions. All four known interferons λ signal through binding to the extracellular domains of IL-28 receptor 1 (IL-28R1) and IL-10 receptor 2 (IL-10R2). Our binders were therefore trained to bind both receptors simultaneously. The bifunctional binder molecules were developed by yeast display, a method of directed evolution. The signaling capacity of the bivalent binders was tested by measuring phosphorylation of the JAK/STAT signaling pathway and production of mRNA of six selected genes naturally induced by IFN- λ1 in human cell lines. The newly developed bivalent binders offer opportunities to study cytokine-related biological functions and modulation of the cell behavior by receptor activation on the cell surfaces alternative to the use of natural IFN-λ.
650    _2
$a antivirové látky $x metabolismus $7 D000998
650    _2
$a cytokiny $x metabolismus $7 D016207
650    _2
$a lidé $7 D006801
650    12
$a interferony $x metabolismus $7 D007372
650    12
$a interleukiny $x metabolismus $7 D007378
650    _2
$a signální transdukce $7 D015398
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Zahradník, Jiří $u Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel $1 https://orcid.org/0000000286984236
700    1_
$a Huličiak, Maroš $u Institute of Biotechnology of the Czech Academy of Sciences, BIOCEV, Vestec, Czech Republic
700    1_
$a Mikulecký, Pavel $u Institute of Biotechnology of the Czech Academy of Sciences, BIOCEV, Vestec, Czech Republic $1 https://orcid.org/0000000328380335
700    1_
$a Peleg, Yoav $u Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel
700    1_
$a Shemesh, Maya $u Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel
700    1_
$a Schreiber, Gideon $u Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel $1 https://orcid.org/0000000229225882
700    1_
$a Schneider, Bohdan $u Institute of Biotechnology of the Czech Academy of Sciences, BIOCEV, Vestec, Czech Republic $1 https://orcid.org/0000000178553690
773    0_
$w MED00008414 $t The FEBS journal $x 1742-4658 $g Roč. 289, č. 9 (2022), s. 2672-2684
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34826176 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220720 $b ABA008
991    __
$a 20220804134841 $b ABA008
999    __
$a ok $b bmc $g 1822249 $s 1169802
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 289 $c 9 $d 2672-2684 $e 20211207 $i 1742-4658 $m The FEBS journal $n FEBS J $x MED00008414
LZP    __
$a Pubmed-20220720

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...